6-gingerol interferes with amyloid-beta (Aβ) peptide aggregation
Berntsson, E.; Paul, S.; Sholts, S. B.; Jarvet, J.; Barth, A.; Graslund, A.; Warmlander, S. K. T. S.
Show abstract
Alzheimers disease (AD) is the most prevalent age-related cause of dementia. AD affects millions of people worldwide, and to date there is no cure. The pathological hallmark of AD brains is deposition of amyloid plaques, which mainly consist of amyloid-{beta} (A{beta}) peptides, commonly 40 or 42 residues long, that have aggregated into amyloid fibrils. Intermediate aggregates in the form of soluble A{beta} oligomers appear to be highly neurotoxic. Cell and animal studies have previously demonstrated positive effects of the molecule 6-gingerol on AD pathology. Gingerols are the main active constituents of the ginger root, which in many cultures is a traditional nutritional supplement for memory enhancement. Here, we use biophysical experiments to characterize in vitro interactions between 6-gingerol and A{beta}40 peptides. Our experiments with atomic force microscopy imaging, and nuclear magnetic resonance and Thioflavin-T fluorescence spectroscopy, show that the hydrophobic 6-gingerol molecule interferes with formation of A{beta}40 aggregates, but does not interact with A{beta}40 monomers. Thus, together with its favourable toxicity profile, 6-gingerol appears to display many of the desired properties of an anti-AD compound.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Peptides derived from gp43, the most antigenic protein from Paracoccidioides brasiliensis, form amyloid fibrils in vitro: implications for vaccine development 94%
- PapRIV, a BV-2 microglial cell activating quorum sensing peptide 92%
- Conformation and membrane interaction studies of the potent antimicrobial and anticancer peptide palustrin-Ca 91%
Similar papers in this journal
- A systematic mutational analysis identifies a 5-residue proline tag that enhances the in vivo immunogenicity of a non-immunogenic model protein 240 folds 88%
- An Enzyme-Linked Immunosorbent Assay (ELISA)-based Activity Assay for AMP-Activated Protein Kinase (AMPK) 88%
- Structural insights into Charcot-Marie-Tooth disease-linked mutations in human GDAP1 87%
Similar papers in this journal
Similar papers in this journal
- Suppression of amyloid-β secretion from neurons by cis-9, trans-11-octadecadienoic acid, an isomer of conjugated linoleic acid 93%
- A validated quantitative method for the assessment of neuroprotective barrier impairment in neurodegenerative disease models 93%
- A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: towards improving experimental reproducibility in α-synuclein research 92%
Similar papers in this journal
- Membrane interactions accelerate the self-aggregation of huntingtin exon 1 fragments in a polyglutamine length-dependent manner 93%
- The bacterial amyloids phenol soluble modulins from Staphylococcus aureus catalyze alpha-synuclein aggregation 92%
- Bilayer-forming lipids enhance archaeal monolayer membrane stability 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.